----
About

Psyence Biomedical
PBM.US
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd.
Profile
- Company Name
- Psyence Biomedical Ltd.
- Market
- NasdaqCM
- Founded
- --
- Industry
- --
- Fiscal Year End
- --
- Website
- yencebiomed.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
